Federated Hermes
ATTO

Federated Hermes’s Attovia Therapeutics ATTO Stock Holding History

Federated Hermes’s Portfolio ATTO Stock Details ATTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$12M Buy
+700,000
New +$14.7M 0.02% 628

Other funds holding ATTO

Sanofi
Sanofi Paris, France $630M AUM 104.49% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Nantahala Capital Management
Nantahala Capital Management New Canaan, Connecticut $3.16B AUM 31.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Vivo Capital
Vivo Capital Palo Alto, California $909M AUM 385.65% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Spruce Street Capital
Spruce Street Capital New York $629M AUM 210.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $132M AUM 92.09% 1-Year Est. Return

Federated Hermes's ATTO Position: Q3 2026 in Review

Federated Hermes opened a new position in Attovia Therapeutics (ATTO) in Q3 2026: 700,000 shares worth $12M. The stake represents 0.02% of the portfolio and ranks #628 among its holdings.

27 funds tracked by Wall St. Rank hold ATTO as of Q3 2026.

  • Federated Hermes held 700,000 shares of Attovia Therapeutics worth $12M as of Q3 2026.
  • Attovia Therapeutics was a new Federated Hermes position in Q3 2026.
  • Attovia Therapeutics made up 0.02% of Federated Hermes's portfolio in Q3 2026, its #628 holding.
  • 27 funds tracked by Wall St. Rank held Attovia Therapeutics as of Q3 2026.

Based on Federated Hermes's 13F filing for Q3 2026, filed 12 Nov 2026.